Aytu BioPharma Ownership | Who Owns Aytu BioPharma?


OverviewForecastRevenueFinancialsChartTranscripts

Aytu BioPharma Ownership Summary


Aytu BioPharma is owned by 6.57% institutional investors, 8.98% insiders, and 84.44% retail investors. Nantahala capital management is the largest institutional shareholder, holding 10.83% of AYTU shares. Philotimo Focused Growth and Income is the top mutual fund, with 2.11% of its assets in Aytu BioPharma shares.

AYTU Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAytu BioPharma6.57%8.98%84.44%
SectorHealthcare Stocks 35.34%11.88%52.77%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.67%13.90%65.43%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nantahala capital management1.09M10.83%$2.97M
Stonepine capital management792.29K7.89%$2.16M
Awm investment company619.57K6.17%$1.69M
Diadema partners lp353.08K3.52%$963.90K
Vanguard group278.58K2.78%$724.32K
Crown advisors management145.00K1.44%$395.00K
Two sigma investments, lp121.97K1.22%$332.99K
Renaissance93.72K0.93%$255.86K
Persistent asset partners92.90K0.93%$253.61K
Geode capital management92.64K0.92%$252.93K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management792.29K0.87%$2.16M
Crown advisors management145.00K0.26%$395.00K
Awm investment company619.57K0.19%$1.69M
Diadema partners lp353.08K0.16%$963.90K
Nantahala capital management1.09M0.11%$2.97M
Persistent asset partners92.90K0.09%$253.61K
Bellevue asset management25.01K0.03%$68.28K
Xtx topco21.58K0.00%$58.92K
Renaissance93.72K0.00%$255.86K
Two sigma investments, lp121.97K0.00%$332.99K

Top Buyers

HolderShares% AssetsChange
Crown advisors management145.00K0.26%145.00K
Diadema partners lp353.08K0.16%47.29K
Vanguard fiduciary trust47.05K-47.05K
Two sigma advisers, lp39.80K0.00%39.80K
Citadel advisors36.84K-21.29K

Top Sellers

HolderShares% AssetsChange
Kanen wealth management---573.36K
Armistice capital---57.60K
Fny investment advisers---31.60K
Drw securities---29.37K
Stonepine capital management792.29K0.87%-21.41K

New Positions

HolderShares% AssetsChangeValue
Crown advisors management145.00K0.26%145.00K$395.00K
Vanguard fiduciary trust47.05K-47.05K$128.44K
Two sigma advisers, lp39.80K0.00%39.80K$74.82K
Jpmorgan chase154.00-154.00$405.00
Rockefeller capital management10.00-10.00$27.00

Sold Out

HolderChange
Northwestern mutual wealth management-1.00
Barclays-1.00
Citigroup-1.00
Sjs investment consulting-5.00
Raymond james financial-55.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202617-54.05%659,738-82.51%60.47%7-58.82%1-83.33%
Dec 31, 202523-25.81%3,133,800-12.47%310.96%6-64.71%5150.00%
Sep 30, 202529-3,580,1494.81%571.84%1741.67%2-60.00%
Jun 30, 2025307.14%3,416,18182.04%555.95%129.09%6200.00%
Mar 31, 202528-1,876,599-0.22%303.25%11-8.33%2-60.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Philotimo Focused Growth and Income189.21K2.11%189.21K
Vanguard Total Stock Mkt Idx Inv169.00K1.57%-
Vanguard Institutional Extnd Mkt Idx Tr92.15K0.86%29.61K
Fidelity Extended Market Index50.41K0.47%6.13K
Spartan Extended Market Index Pool E11.89K0.19%280.00
Perritt MicroCap Opportunities Investor20.00K0.19%20.00K
NT Ext Equity Mkt Idx Fd - L15.32K0.14%-
Northern Trust Extended Eq Market Idx15.32K0.14%9.01K
Spartan Extended Market Index Pool F13.44K0.13%193.00
Fidelity Series Total Market Index11.93K0.11%2.18K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2025Disbrow Jarrett Chief Business OfficerBuy$25.00K
Jun 09, 2025Disbrow Joshua R. Chief Executive OfficerBuy$100.00K
Jun 06, 2025Nantahala Capital Management, LLC-Buy$400.00
Feb 28, 2025Disbrow Joshua R. Chief Executive OfficerBuy$19.50K
Jun 16, 2023PYSZCZYMUKA GREG Chief Commerical OfficerBuy$22.43K

Insider Transactions Trends


DateBuySell
2025 Q23-
2025 Q11-
2024 Q4--
2024 Q3--
2024 Q2--

AYTU Ownership FAQ


Who Owns Aytu BioPharma?

Aytu BioPharma shareholders are primarily institutional investors at 6.57%, followed by 8.98% insiders and 84.45% retail investors. The average institutional ownership in Aytu BioPharma's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Aytu BioPharma falls below.

Who owns the most shares of Aytu BioPharma?

Aytu BioPharma’s largest shareholders are Nantahala capital management (1.09M shares, 10.83%), Stonepine capital management (792.29K shares, 7.89%), and Awm investment company (619.57K shares, 6.17%). Together, they hold 24.90% of Aytu BioPharma’s total shares outstanding.

Does Blackrock own Aytu BioPharma?

BlackRock is not among the top 10 institutional shareholders of Aytu BioPharma.

Who is Aytu BioPharma’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is Aytu BioPharma’s biggest shareholder by percentage of total assets invested, with 0.87% of its assets in 792.29K Aytu BioPharma shares, valued at 2.16M$.

Who is the top mutual fund holder of Aytu BioPharma shares?

Philotimo Focused Growth and Income is the top mutual fund holder of Aytu BioPharma shares, with 2.11% of its total shares outstanding invested in 189.21K Aytu BioPharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools